New Alzheimer’s Disease Treatments

Clinical trials are paving the way for a future without Alzheimer’s disease

New Alzheimer’s disease treatments are now available in international clinical trials

"*" indicates required fields

Step 1 of 2

Name*

Hope for Alzheimer’s disease

Global memory studies are investigating new treatments for Alzheimer’s disease. By taking part in a study, you could access disease-modifying medications and specialist mental healthcare, at no cost.

These new drugs aim to keep the brain cells alive in order to reduce the progression of memory impairment. There are lots of studies open across the world. We run a number of clinical trials at our centers in London, Guildford, Plymouth and Birmingham. If you’d like to find out more about which study could be right for you, or somebody you know, speak to a specialist today

Disease-modifying treatments target the pathology of the disease. Symptomatic medications on the other hand, aim to improve the symptoms associated with Alzheimer’s. For example, some disease-modifying treatments work to reduce the levels of B amyloid & Tau Protein in the brain. Others alter genetic and inflammatory markers. You can find out more about how the new treatments work by completing the sign-up form at the bottom of this page.

Four Re:Cognition Health Centers, one international community of experts

Importantly, the protocol for a clinical trial is the same across the world. As a result, if you volunteer for a study in the UK, you’ll receive the exact same standard of care and medical monitoring as a volunteer taking part in Australia. In addition, advanced imaging assessments, like MRI scans and PET scans, are provided at no cost. PET scans are not typically provided on the NHS. Similarly, you may benefit from regular health check-ups, including blood tests and ECGs. Therefore, if you choose to volunteer for a study at a private Center or in the NHS, you will receive the same standard of care and support.

Independent ethics committees review and approve clinical trials before a volunteer can sign up for a study. The NHS Health Research Authority comments: “review by an ethics committee is one of a series of safeguards intended to protect the people taking part in the research. These are set out in a series of documents and guidance”.

Our exceptional patient-centric care has been recognized by a number of prestigious awards. As a result of our professionalism and commitment to patient recruitment, our centers have been the top global-recruiting centres for a number of clinical trials.

“If someone has a diagnosis of Alzheimer’s Disease I would say get in touch with Re:Cognition Health: they are doing excellent work and look after you so well throughout the process”

Study partner of clinical trial volunteer

An individual contribution with a phenomenal global impact

You could help develop new medications for the disease by taking part in an Alzheimer’s, dementia, and memory loss trial. Clinical trials are important because they investigate the effectiveness and safety profile of new drugs. Even paracetamol went through a clinical trial at one stage!

Volunteers have access to award-winning private healthcare and specialist assessments. These include MRI and PET scans. In addition, travel expenses are reimbursed for each Center appointment. We’ve listed some of the potential benefits of joining a study below. If you’d like to learn more about participating in a study, simply complete the sign-up form at the bottom of this page.

Volunteer Opportunities – Potential Benefits

  • Early access to new treatments for memory loss
  • Outstanding medical care is provided at no cost, including comprehensive health screens, MRI scans and PET scans
  • Avoid lengthy NHS waiting lists and access expert care in a private Center setting
  • Reimbursement of travel expenses and complimentary refreshments
  • Prevent the onset of memory problems
  • Change the future of Alzheimer’s; help develop dementia syndrome and memory loss treatments for future generations
Register Now!